Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series
- PMID: 33610347
- PMCID: PMC7877203
- DOI: 10.1016/j.neurol.2021.01.004
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series
Abstract
Background: Neurological disorders associated with SARS-CoV-2 infection represent a clinical challenge because they encompass a broad neurological spectrum and may occur before the diagnosis of COVID-19.
Methods: In this monocentric retrospective case series, medical records from patients with acute neurological disorders associated with SARS-CoV-2 infection from medicine departments of an academic center in Paris area were collected between March 15th and May 15th 2020. Diagnosis of SARS-CoV-2 was ascertained through specific RT-PCR in nasopharyngeal swabs or based on circulating serum IgG antibodies.
Results: Twenty-six patients diagnosed with SARS-CoV-2 infection presented with neurological disorders: encephalitis (N=8), encephalopathy (N=6), cerebrovascular events (ischemic strokes N=4 and vein thromboses N=2), other central nervous system (CNS) disorders (N=4), and Guillain-Barré syndrome (N=2). The diagnosis of SARS-CoV-2 was delayed on average 1.6 days after the onset of neurological disorder, especially in case of encephalitis 3.9 days, encephalopathy 1.0 day, and cerebrovascular event 2.7 days.
Conclusions: Our study confirms that COVID-19 can yield a broad spectrum of neurological disorders. Because neurological presentations of COVID-19 often occur a few days before the diagnosis of SARS-COV-2 infection, clinicians should take preventive measures such as patient isolation and masks for any new admission to avoid nosocomial infections. Anti-SARS-CoV2 antibody detection in RT-PCR SARS CoV-2 negative suspected cases is useful to confirm a posteriori the diagnosis of atypical COVID-19 presentations.
Keywords: Amyotrophic Lateral Sclerosis; Diaphragmatic ultrasonography; Phrenic nerve conduction; Pulmonary function tests.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16. Rev Neurol (Paris). 2021. PMID: 33446327 Free PMC article. Review.
-
Neurologic manifestations associated with COVID-19: a multicentre registry.Clin Microbiol Infect. 2021 Mar;27(3):458-466. doi: 10.1016/j.cmi.2020.11.005. Epub 2020 Nov 13. Clin Microbiol Infect. 2021. PMID: 33189873 Free PMC article.
-
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.Brain. 2020 Oct 1;143(10):3104-3120. doi: 10.1093/brain/awaa240. Brain. 2020. PMID: 32637987 Free PMC article.
-
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.J Neuroinflammation. 2022 Jan 20;19(1):19. doi: 10.1186/s12974-021-02339-0. J Neuroinflammation. 2022. PMID: 35057809 Free PMC article.
-
Neurological Complications of COVID-19: Underlying Mechanisms and Management.Int J Mol Sci. 2021 Apr 15;22(8):4081. doi: 10.3390/ijms22084081. Int J Mol Sci. 2021. PMID: 33920904 Free PMC article. Review.
Cited by
-
COGNITIVE, NEUROLOGICAL, NEUROPSYCHOLOGICAL AND NEUROPSYCHIATRIC ALTERATIONS IN POST-COVID-19 PATIENTS.Actas Esp Psiquiatr. 2023 May;51(3):88-97. Epub 2023 May 1. Actas Esp Psiquiatr. 2023. PMID: 37489554 Free PMC article.
-
Neurological manifestation in COVID-19 disease with neuroimaging studies.Am J Neurodegener Dis. 2023 Apr 15;12(2):42-84. eCollection 2023. Am J Neurodegener Dis. 2023. PMID: 37213710 Free PMC article. Review.
-
Comparison of Disease Profiles and Three-Month Outcomes of Patients with Neurological Disorders with and without COVID-19: An Ambispective Cohort Study.Ann Indian Acad Neurol. 2022 Mar-Apr;25(2):218-223. doi: 10.4103/aian.aian_602_21. Epub 2022 Mar 1. Ann Indian Acad Neurol. 2022. PMID: 35693663 Free PMC article.
-
Autoimmune complications of COVID-19.J Med Virol. 2022 Jan;94(1):54-62. doi: 10.1002/jmv.27292. Epub 2021 Aug 31. J Med Virol. 2022. PMID: 34427929 Free PMC article. Review.
-
What can the neurological manifestations of COVID-19 tell us: a meta-analysis.J Transl Med. 2021 Aug 23;19(1):363. doi: 10.1186/s12967-021-03039-2. J Transl Med. 2021. PMID: 34425827 Free PMC article.
References
-
- Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. Neurologic Manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol [Internet] 2020:549. [Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549 (Internet, cited 2020 Apr 11)] - PMC - PubMed
-
- Duong L., Xu P., Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun [Internet] 2020 [Available from: http://www.sciencedirect.com/science/article/pii/S0889159120305092 (Internet, cited 2020 May 27)] - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous